SPECTRUM PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Spectrum Pharmaceuticals Inc. Investors of the Lead Plaintiff Deadline in Securities Class Action
08 nov. 2016 09h30 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) of the securities class action lawsuit and...
SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Spectrum Pharmaceuticals Inc. Investors to Expanded Class Period and Lead Plaintiff Deadline
05 oct. 2016 09h30 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 05, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) to the expanded class period in the Nevada U.S....
SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Spectrum Pharmaceuticals Inc. Investors to Class Action and Lead Plaintiff Deadline
23 sept. 2016 09h30 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISO, Sept. 23, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) to the securities class action lawsuit filed in the...
SPECTRUM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman is Investigating Possible Securities Law Violations by Spectrum Pharmaceuticals Inc. and Officers
21 sept. 2016 09h30 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 21, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) that the firm is investigating possible securities...